These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23835309)

  • 61. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.
    Wu X; Mastronicola R; Tu Q; Faure GC; De Carvalho Bittencourt M; Dolivet G
    BMC Cancer; 2016 Jul; 16():552. PubMed ID: 27465596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Enrichment and detection of circulating tumor cells and its application in head and neck squamous cell carcinoma].
    Zhang HD; Yu ZK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):147-151. PubMed ID: 28219182
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
    Wu XL; Tu Q; Faure G; Gallet P; Kohler C; Bittencourt Mde C
    Sci Rep; 2016 Feb; 6():20210. PubMed ID: 26831813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review.
    Rave-Fränk M
    Cancer Radiother; 2017 Oct; 21(6-7):554-556. PubMed ID: 28847459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view.
    Mangano A; Mangano A; Lianos GD; Levrini L; Picone M; Boni L; Dionigi G
    Future Oncol; 2015; 11(13):1851-3. PubMed ID: 26161921
    [No Abstract]   [Full Text] [Related]  

  • 67. Nanomedical detection and downstream analysis of circulating tumor cells in head and neck patients.
    Künzel J; Gribko A; Lu Q; Stauber RH; Wünsch D
    Biol Chem; 2019 Oct; 400(11):1465-1479. PubMed ID: 30903749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating Proteasomes in the Pathogenesis of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Cheremisina OV; Choinzonov EL; Kondakova IV
    Bull Exp Biol Med; 2017 May; 163(1):92-94. PubMed ID: 28577090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.
    Chen MH; Chang PM; Chen PM; Tzeng CH; Chu PY; Chang SY; Yang MH
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1783-90. PubMed ID: 19551407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck.
    Maxim PE; Veltri RW
    Cancer; 1986 Jan; 57(2):305-11. PubMed ID: 3942962
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
    Dent BM; Ogle LF; O'Donnell RL; Hayes N; Malik U; Curtin NJ; Boddy AV; Plummer ER; Edmondson RJ; Reeves HL; May FE; Jamieson D
    Int J Cancer; 2016 Jan; 138(1):206-16. PubMed ID: 26178530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cell line dependent expression of EpCAM influences the detection of circulating tumor cells with CellSearch.
    Lindgren G; Wennerberg J; Ekblad L
    Laryngoscope Investig Otolaryngol; 2017 Aug; 2(4):194-198. PubMed ID: 28894840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up.
    Möckelmann N; Laban S; Pantel K; Knecht R
    Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):15-21. PubMed ID: 23408023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Crystallization test in patients with head and neck neoplasms].
    Kuczkowski J; Zaorski P; Betlejewski A
    Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Circulating tumor cells in head and neck cancer].
    Guntinas-Lichius O; Pachmann K
    Laryngorhinootologie; 2015 Jun; 94(6):367-72. PubMed ID: 26039038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck.
    Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
    Cancer Lett; 1998 Aug; 130(1-2):49-56. PubMed ID: 9751256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating tumor cells in the blood of poorly differentiated nasal squamous cell carcinoma patients: correlation with treatment response.
    Li F; Liu J; Song D; Zhang Q; Ding N; He X
    Acta Otolaryngol; 2016 Nov; 136(11):1164-1167. PubMed ID: 27387761
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of squamous cell carcinomas of the head and neck using methods of spatial statistics.
    Mattfeldt T; Fleischer F
    J Microsc; 2014 Oct; 256(1):46-60. PubMed ID: 25142175
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The mechanical spread of viable tumor during surgery.
    Atiyah RA; Krespi YP; Hidvegi D; Sisson GA
    Otolaryngol Head Neck Surg; 1986 Mar; 94(3):278-81. PubMed ID: 3083353
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.
    Klapan I; Katić V; Culo F; Cuk V
    J Cancer Res Clin Oncol; 1992; 118(4):308-13. PubMed ID: 1577849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.